SoftBank leads funding that could net up to $525M for Exscientia’s AI drug platform
aalidrus
Wed, 04/28/2021 – 09:35
SoftBank leads funding that could net up to $525M for Exscientia’s AI drug platform
Read more on FierceBiotech
You may also like
news & analysis
Madrid-based ifeel raises €5.5 million to democratise access to therapy
May 7, 2021, by Charlotte Tucker
ifeel, the emotional well-being platform transforming how employees access therapy, has raised €5.5 million series A round ...
Read more on EU-Startups
news & analysis
Verge Genomics Names Robert Scannevin, Ph.D., Chief Scientific Officer
May 6, 2021, by Business Wire Technology News
SAN FRANCISCO–(BUSINESS WIRE)–Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique ...
Read more on Business Wire Technology News
news & analysis
Fertility in Crisis: Alife Health Aims to Improve Health Equity and Outcomes Using AI
May 3, 2021, by Business Wire Technology News
SAN FRANCISCO–(BUSINESS WIRE)–1 in 8 families now struggle with infertility. Studies show that the average healthy couple ...
Read more on Business Wire Technology News
More in SDG 3. GOOD HEALTH & WELL-BEING
news & analysis
David Cannington, Co-Founder of Nuheara – Interview Series
April 30, 2021, by Antoine Tardif
David Cannington is the Co-Founder & Chief Marketing Officer of Nuheara, a global leader in smart earbuds ...
Read more on Unite.AI
news & analysis
How Verge Genomics Uses AI To Tackle Parkinson’s, Alzheimer’s And ALS
April 29, 2021, by Aayushi Pratap, Forbes Staff
Using a combination of machine learning and proprietary data, CEO Alice Zhang is looking to develop more ...
Read more on Forbes - AI
news & analysis
Israeli researchers use AI to fight intestinal diseases
April 26, 2021, by JPost.com - Home
The new method could be a gateway to create new smart drugs that can neutralize the protein ...
Read more on JPost.com - Home